{
    "2018-01-11": [
        [
            {
                "time": "",
                "orginal_text": "年报披露即将，擦亮双眼提前甄选业绩真增长公司",
                "features": {
                    "keywords": [
                        "年报",
                        "业绩增长"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "全行业"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "orginal_text": "医药生物行业1月月报：把握年底估值切换行情布局2018",
                "features": {
                    "keywords": [
                        "医药生物",
                        "估值切换",
                        "布局2018"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "orginal_text": "恒瑞医药最新消息：BTK抑制剂授权TGTtherapeutics 走出去战略加速",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "BTK抑制剂",
                        "走出去战略"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "orginal_text": "中国平安、京东方A、美的集团入选2018“下注中国”十大核心资产",
                "features": {
                    "keywords": [
                        "中国平安",
                        "京东方A",
                        "美的集团",
                        "核心资产"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融",
                        "科技",
                        "家电"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "orginal_text": "医药行业三大细分市场率先受益(附股)",
                "features": {
                    "keywords": [
                        "医药行业",
                        "细分市场",
                        "受益"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "orginal_text": "安信国际 | 石药集团(1093)：收购友芝友股权，拓展生物药领域",
                "features": {
                    "keywords": [
                        "石药集团",
                        "收购",
                        "生物药"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "orginal_text": "两融余额三连升再创新高 京东方A成融资客首选标的",
                "features": {
                    "keywords": [
                        "两融余额",
                        "京东方A",
                        "融资"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "orginal_text": "康美药业连发五公告，斥资超10亿元寓意几何？",
                "features": {
                    "keywords": [
                        "康美药业",
                        "公告",
                        "斥资"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "orginal_text": "2017年中国药企获批准的ANDA",
                "features": {
                    "keywords": [
                        "药企",
                        "ANDA",
                        "批准"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "orginal_text": "【陆股通交易追踪】陆港通净买入 银行股获青睐 茅台等白酒股遭减持",
                "features": {
                    "keywords": [
                        "陆港通",
                        "银行股",
                        "白酒股",
                        "减持"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融",
                        "消费"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "mixed",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "mixed"
                }
            },
            {
                "time": "",
                "orginal_text": "【医药】恒瑞医药(600276): BTK抑制剂海外授权，创新药全球化布局更进一步",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "BTK抑制剂",
                        "海外授权",
                        "全球化布局"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "orginal_text": "恒瑞医药：第七届董事会第十八次会议决议公告",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "董事会决议"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "orginal_text": "英媒：恒瑞医药向美TG公司授权新药研发许可",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "新药研发",
                        "授权"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}